This is the authors' abstract. We don't add key points for this paper.
Radiofrequency thermocoagulation (RFTC) guided by stereo-electroencephalography (SEEG) is a minimally invasive treatment for drug-resistant epilepsy, but the coagulation distribution is constrained by diagnostic electrode placement. In this exploratory case series, we evaluated the technical feasibility, intraoperative workflow, and preliminary safety of robot-assisted stereotactic RFTC with trajectories planned independently of diagnostic electrodes, targeting the SEEG-defined seizure-onset zone and, when coverage permitted, early propagation regions. We retrospectively analyzed six patients who underwent robot-assisted stereotactic RFTC with SEEG-based independent therapeutic trajectory (ITT) planning between February 2024 and February 2026. The epileptogenic zone was delineated by integrating SEEG, anatomical imaging, and clinical information. A monopolar probe was robotically guided along each trajectory, and stepwise pull-back coagulation was combined across trajectories to create a three-dimensional ablation. Surgical parameters, ablation distribution, and adverse events were assessed descriptively. Probe insertion and multi-trajectory ablation were completed as planned in all six procedures, with a mean of 5.3 ± 2.7 trajectories and 21.8 ± 14.7 coagulation points. Mean operative and operating room times were 145.7 ± 54.7 and 276.0 ± 45.8 min, respectively. No hemorrhage or infection occurred; however, one patient developed permanent homonymous hemianopia consistent with optic radiation injury, a major complication. At the last follow-up, four of six patients achieved Engel class I–II outcomes; given the small, heterogeneous sample, these findings do not establish treatment efficacy. Robot-assisted stereotactic RFTC enabled three-dimensional ablation unconstrained by diagnostic electrode placement. However, the permanent visual-field deficit highlights the need for particular caution near major white matter tracts because of the risk of off-target injury. Although clinical efficacy remains unproven, this study demonstrates the feasibility of a systematic, transferable planning framework that, building on lesion-guided RFTC, translates SEEG findings into independent therapeutic trajectories, and underscores the importance of preoperative planning that prioritizes white matter preservation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: